Increased vascular endothelial growth factor production in fibroblasts isolated from strictures in patients with Crohn's disease
Authors:
- 1 January 2004
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 91 (1) , 72-77
Abstract
Background: Vascular endothelial growth factor (VEGF) is a potent angiogenic factor that is implicated in early wound healing and fibrosis. Fibroblasts may initiate stricture formation in Crohn's disease through overexpression of VEGF. The aim of this study was to examine VEGF expression and regulation in fibroblasts isolated from patients with Crohn's disease. Methods: Fibroblasts were isolated by a primary explant technique from serosal biopsies of non-strictured and strictured segments of bowel from eight patients undergoing resection for Crohn's disease, and normal colon from six patients undergoing resection for benign and malignant colorectal disease. Fibroblasts were cultured with transforming growth factor (TGF) β and corticosteroids. After 24 h the culture supernatant was collected for VEGF assay by enzyme-linked immunosorbent assay. Results: VEGF production was significantly higher in fibroblasts isolated from strictures (mean(s.e.m.) 1980(260) pg/ml) than from non-strictured segments (1116(165) pg/ml) in patients with Crohn's disease or control fibroblasts (898(93) pg/ml). TGF-β increased VEGF production in normal and non-strictured Crohn's fibroblasts. Corticosteroids suppressed unstimulated VEGF production in all groups. Conclusion: Enhanced serosal fibroblast VEGF production might play a role in initiating stricture formation in Crohn's disease. VEGF production in serosal fibroblasts is sensitive to stimulation with TGF-β. Corticosteroids may reduce stricturing through suppression of VEGF.Keywords
Funding Information
- Mater College, Dublin, Ireland
This publication has 27 references indexed in Scilit:
- Increased Adhesion Molecule Expression in Serosal Fibroblasts Isolated From Patients with Inflammatory Bowel Disease is Secondary to InflammationAnnals of Surgery, 2002
- Mechanism of transforming growth factor-β1-induced expression of vascular endothelial growth factor in murine osteoblastic MC3T3-E1 cellsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2000
- Stricture Formation in Crohn’s DiseaseAnnals of Surgery, 2000
- Hypoxia augments cytokine (transforming growth factor-beta (TGF-β) and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblastsClinical and Experimental Immunology, 1999
- TGFβ-1 regulation of VEGF production by breast cancer cellsAnnals of Surgical Oncology, 1997
- Increased collagen type III synthesis by fibroblasts isolated from strictures of patients with Crohn's diseaseGastroenterology, 1992
- Vascular Endothelial Growth Factor Is a Secreted Angiogenic MitogenScience, 1989
- PATHOGENESIS OF CROHN'S DISEASE: MULTIFOCAL GASTROINTESTINAL INFARCTIONThe Lancet, 1989
- Collagen content and types in the intestinal strictures of Crohn's diseaseGastroenterology, 1988
- Long-term follow-up of patients with Crohn's diseaseGastroenterology, 1985